A Multicenter Study of Docetaxel at a Dose of 100 mg/m(2) in Japanese Patients with Advanced or Recurrent Breast Cancer

OBJECTIVE: This study examined the pharmacokinetics, safety and anti-tumor activity of docetaxel at a dose of 100 mg/m(2) in Japanese patients with advanced or recurrent breast cancer. METHODS: Japanese patients with advanced or recurrent breast cancer received docetaxel at a dose of 100 mg/m(2) int...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Intern Med
Glavni autori: Hirata, Taizo, Ozaki, Shinji, Tabata, Masahiro, Iwamoto, Takayuki, Hinotsu, Shiro, Hamada, Akinobu, Motoki, Takayuki, Nogami, Tomohiro, Shien, Tadahiko, Taira, Naruto, Matsuoka, Junji, Doihara, Hiroyoshi
Format: Artigo
Jezik:Inglês
Izdano: The Japanese Society of Internal Medicine 2020
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8112988/
https://ncbi.nlm.nih.gov/pubmed/33191320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.5089-20
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items